Skip to Content

New Treatments for Alzheimer’s Disease with Anti-Amyloid Antibodies

At EAN 2024, Kristian Steen Frederiksen from the Danish Dementia Research Center chaired a session that broadly focused on the ongoing steps forward in understanding the pathophysiology and disease mechanisms of Alzheimer’s disease. In this MEDtalk, he briefly discusses some of the session’s highlights.

Kristian Steen Frederiksen

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top